The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Patent Reform

Mixed Reaction to U.S. Patent Reform

Guest post by Andrew Franklin, a colleague in the Pharmaceuticals and Life Sciences practice at Norton Rose. With the passage of the America Invents Act of 2011, the United States’ patent system will change from a “first-to-invent” system to a “first-to-file” system for granting patents. Under the new system, patents will be granted to the first [...]

Biotech Trends of 2009: Three Biggest Losers

When we started the blog almost a year ago, we identified what we thought would be key trends for biotech investors and companies to watch.  Most panned out, but a few turned out to be… not so trendy.  You can call them premature (if you’re feeling generous) or call them dumb (if you’re feeling mean); [...]

Trends Update — Biosimilars: Sen. Kennedy, Gov. Dean and NVCA Study all Support 12+ Years of Exclusivity

The debate over the proper data exclusivity period for innovator biologics (as protection against biosimilars/follow-on biologics/subsequent-entry biologics) had a busy week last week. On Wednesday, two Democrats told the Obama administration where to stick its 7-year “generous compromise”:  Howard Dean published an op-ed supporting a 12-year exclusivity period and Bloomberg wrote up a renewed effort [...]

BIO 2009: Monday Technology Transfer Breakfast

I was at breakfast yesterday morning with university and company members of the BIO Technology Transfer Committee.  Some interesting tidbits, colo(u)red by my preception and commentary and not to be attributed to any other attendees: A lot of the stated support for the Senate patent reform bill is soft and is based on the assumption/condition that [...]

The Week Ahead on Capitol Hill

HHS-Secretary elect Kathleen Sebelius will have confirmations before the Senate Health, Education, Labor and Pensions Committee on Tuesday, March 31, followed by the Senate Finance Committee on April 2.  Both hearings should cover topics such as universal health care and comparative effectiveness.  The first hearing would also address issues like public health preparedness and health innovation, [...]

Patent Reform Live (Updated): Senate Judiciary Committee Hearings

You can watch the Senate Judiciary Committee hearings live here starting at 10 am. Here’s a letter sent yesterday (pdf) by Sens. Feingold, Wyden, Bond, Brownback, Grassley, Kyl and Coburn to Sens. Leahy and Hatch expressing the writers’ concerns. Witness list and links to the witness statements

The Patent Reform Act of 2009: Absent Inequitable Conduct Provisions Help Biotech

The Patent Reform Act of 2009 was introduced by Senator Patrick Leahy (D-VT) Chairman of the Senate Judiciary Committee. The bill includes Senator Orrin Hatch (R-UT) as a co-sponsor. Notably missing from the list of co-sponsors is Senator Arlen Specter (R-PA), Ranking Republican on the Judiciary Committee. Provisions relating to inequitable conduct have been removed [...]

Follow

Get every new post delivered to your Inbox.

Join 93 other followers